MOUNTAIN VIEW, Calif., Oct. 21, 2016 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Thursday, October 27, 2016, to discuss the Company's third Quarter 2016 financial results.
Omnicell Third Quarter 2016 earnings conference call and webcast
October 27, 2016, 1:30 p.m. PT
Randall Lipps, chairman, president and chief executive officer
Peter Kuipers, chief financial officer
The conference call can be monitored by dialing 1-800-696-5518 within the U.S.
or 1-706-758-4883 for all other locations. The Conference ID # is 4139562.
The webcast can be accessed at: http://ir.omnicell.com/events.cfm.
Link to the Omnicell website 15 minutes prior to the call to download necessary audio software.
Available starting at 4:30 p.m. PT on October 27, 2016 through 11:59 p.m. PT on
December 8, 2016. Dial 1-855-859-2056 within the U.S. and 1-404-537-3406 for all other locations, Conference ID # 4139562.
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.
Over 4,000 customers worldwide use Omnicell automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety. The recent acquisition of Aesynt adds distinct capabilities, particularly in central pharmacy and IV robotics, creating the broadest medication management product portfolio in the industry.
The Omnicell SureMed solution provides innovative medication adherence packaging to help reduce costly hospital readmissions. These medication adherence solutions are used by over 17,000 institutional and retail pharmacies in North America and the United Kingdom. These pharmacies are served via the Company's sales channels and our solutions enable them to
maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.
For more information about Omnicell, Inc. please visit www.omnicell.com.
For more information:
Last updated on: 24/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.